Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibition.
D001419:Bacteria / Q000187:drug effects*; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000494:pharmacology; D015296:Ceftizoxime; D003470:Culture Media; D004355:Drug Stability; D008826:Microbial Sensitivity Tests / Q000592:standards; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000378:metabolism*
D003470:Culture Media; D065093:beta-Lactamase Inhibitors; D015296:Ceftizoxime; D001618:beta-Lactamases; D002439:Cefotaxime